Ardena, a specialist pharmaceutical Contract Development and Manufacturing
Organisation (CDMO), announced today that it has acquired Idifarma.
The acquisition from Suanfarma delivers expansion across Southern Europe and supports Ardena’s strategy to become a leading global CDMO, offering integrated solutions across the full pharma development lifecycle.
In this webinar, Idifarma and Oriento SA will provide useful guidelines and tips for a QbD approach in Spray Drying processes, highlighting the key variables to consider and explaining its application with a case study.Continue Reading
Idifarma has renewed the approval by the French Ministry as an outsourcing partner for R&D activities under the conditions of the Crédit d’Impôt Recherche (CIR).Continue Reading
Idifarma launches Simply to Clinic™, an accelerated pathway for complex drugs.Continue Reading
Today, we interview our Operations Director, Fabiola Pedrosa.Continue Reading
In this new chapter, we are going to talk about one of the experienced professionals in our Business Development areaContinue Reading
With more than 120 employees, the Human Resources team becomes an indispensable part of the companyContinue Reading
Today, we focus on an important area of the company: our analytical laboratory team.Continue Reading
Our experts are preparing the answers to the most relevant questions, which we will post in this Q&A sectionContinue Reading
Our new expert of March, is actually the first employee Idifarma ever had.Continue Reading